FDA Approves Odactra for House Dust Mite Allergies

March 1, 2017 -- The U.S. Food and Drug Administration today approved Odactra, the first allergen extract to be administered under the tongue (sublingually) to treat house dust mite (HDM)-induced nasal inflammation (allergic rhinitis), with or...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news